Boston Scientific Corporation (BSX)

CIK 0000885725 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-29) · 99.1
Q1-2026 8-K (2026-04-22) · 99.1
Latest FY-2025 8-K (2026-02-04) · 99.1
Q3-2025 8-K (2025-10-22) · 99.1
Q2-2025 8-K (2025-07-23) · 99.1
Q1-2025 8-K (2025-04-23) · 99.1
FY-2024 8-K (2025-02-05) · 99.1
Q3-2024 8-K (2024-10-23) · 99.1
Q2-2024 8-K (2024-07-24) · 99.1
Q1-2024 8-K (2024-04-24) · 99.1
FY-2023
FY-2023 8-K (2024-01-31) · 99.1
Q3-2023 8-K (2023-10-26) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Cover Document
—
Audit Information
—
Statements
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Income (loss)
Consolidated Balance Sheets
Consolidated Balance Sheets (unaudited) (P)
—
Consolidated Balance Sheet Paranthetical
—
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (supplemental Disclosure)
—
Notes
Acquisitions and Strategic Investments
—
Acquisitions, Divestitures and Strategic Investments
—
Basis of Presentation
—
Changes In Other Comprehensive Income
Commitments and Contingencies
Contractual Obligations and Commitments
Cybersecurity Risk Management and Strategy Disclosure
—
Employee Retirement Plans (notes)
—
Goodwill and Other Intangible Assets
Hedging Activities and Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Leases
—
New Accounting Pronouncements
Restructuring and Related Activities
—
Revenue
Schedule Ii
—
Segment Reporting
Significant Accounting Policies
—
Stock Inventive and Purchase Plans
—
Stockholders' Equity
Supplemental Balance Sheet Information
Weighted Average Shares Outstanding